Sheila Mcmenamin, in Basking Ridge, NJ - Medicare Nurse Practitioner

Sheila Mcmenamin, is a medicare enrolled "Nurse Practitioner - Primary Care" in Basking Ridge, New Jersey. Her current practice location is 8000 Fellowship Rd, Basking Ridge, New Jersey. You can reach out to her office (for appointments etc.) via phone at (908) 580-3873.

Sheila Mcmenamin is licensed to practice in New Jersey (license number 26NN08634300) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1851894323.

Contact Information

	Sheila Mcmenamin,
	8000 Fellowship Rd, Basking Ridge, NJ 07920-3915
	(908) 580-3873
	(908) 647-2953

Provider's Profile

Full Name	Sheila Mcmenamin
Gender	Female
Speciality	Nurse Practitioner - Primary Care
Location	8000 Fellowship Rd, Basking Ridge, New Jersey
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1851894323
Provider Enumeration Date: 03/12/2018
Last Update Date: 03/12/2018

Medicare PECOS Information:

PECOS PAC ID: 8628331071
Enrollment ID: I20180417001294

Medical Identifiers

Medical identifiers for Sheila Mcmenamin such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1851894323	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
363LP2300X	Nurse Practitioner - Primary Care	26NN08634300 (New Jersey)	Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Sheila Mcmenamin allows following entities to bill medicare on her behalf.

Entity Name	Fellowship Village Inc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1659411437 PECOS PAC ID: 4880506310 Enrollment ID: O20031104000083

News Archive

rVWF safe in patients with type 3 and severe type 1 von Willebrand disease, suggests interim study data

Recombinant von Willebrand factor (rVWF) may be safe and well tolerated in patients with type 3 and severe type 1 von Willebrand disease, according to interim data from a Phase 1 multicenter, international clinical study presented today at the 52nd Annual Meeting of the American Society of Hematology.

Drug use among young adults on the rise in U.S.

Nearly one in 10 Americans report regularly using illegal drugs, including marijuana, cocaine, heroin, hallucinogens, inhalants or prescription drugs used recreationally, according to the National Survey on Drug Use and Health made public today. The survey, sponsored by the federal Substance Abuse and Mental Health Services Administration (SAMHSA), collects the data from interviews with 67,500 randomly selected people 12 years or older.

VA's final rule leads to underutilization of CRNAs in VHA facilities

Despite documented evidence confirming that veterans are experiencing delays for essential healthcare services due to lack of anesthesia support in Veterans Health Administration facilities, the Department of Veterans Affairs has published its final rule granting full practice authority to all advanced practice registered nurses except Certified Registered Nurse Anesthetists.

FDA approves Gilotrif for patients with late stage non-small cell lung cancer

Companion test also approved to identify appropriate patients The U.S. Food and Drug Administration today approved Gilotrif (afatinib) for patients with late stage (metastatic) non-small cell lung cancer (NSCLC) whose tumors express specific types of epidermal growth factor receptor (EGFR) gene mutations, as detected by an FDA-approved test. Lung cancer is the leading cause of cancer-related death among men and women.

Study suggests substantial efforts are needed to help people with HIV durably suppress the virus

Among people with HIV worldwide who are receiving antiretroviral therapy (ART), adults are getting closer to the global target of 95% achieving viral suppression, but progress among children and adolescents is lagging and long-term viral suppression among all groups remains a challenge.

Entity Name	Practitioner Support Services Llp
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1114115706 PECOS PAC ID: 3375596984 Enrollment ID: O20170510000579

rVWF safe in patients with type 3 and severe type 1 von Willebrand disease, suggests interim study data

Drug use among young adults on the rise in U.S.

VA's final rule leads to underutilization of CRNAs in VHA facilities

FDA approves Gilotrif for patients with late stage non-small cell lung cancer

Study suggests substantial efforts are needed to help people with HIV durably suppress the virus

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Sheila Mcmenamin is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Sheila Mcmenamin, 8000 Fellowship Rd, Basking Ridge, NJ 07920-3915 Ph: (908) 580-3873	Sheila Mcmenamin, 8000 Fellowship Rd, Basking Ridge, NJ 07920-3915 Ph: (908) 580-3873

News Archive

rVWF safe in patients with type 3 and severe type 1 von Willebrand disease, suggests interim study data

Drug use among young adults on the rise in U.S.

VA's final rule leads to underutilization of CRNAs in VHA facilities

FDA approves Gilotrif for patients with late stage non-small cell lung cancer

Study suggests substantial efforts are needed to help people with HIV durably suppress the virus

Nurse Practitioner Nurses in Basking Ridge, NJ

Karen Elizabeth Retirado, APN-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 15 Dorchester Drive, Basking Ridge, NJ 07920 Phone: 732-841-5697
Ms. Seeta Vaidehi Verron, MSN, RN, MPH, BA Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 136 Mountainview Blvd, Basking Ridge, NJ 07920 Phone: 908-542-3129
Felicidad Marie I. Santiago, RN, BSN, MSN, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 131 Morristown Rd, Basking Ridge, NJ 07920 Phone: 908-307-8840
Faruk A Ali, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 131 Morristown Rd, Basking Ridge, NJ 07920 Phone: 347-587-9691
Ms. Carly M Osborne, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 136 Mountainview Blvd, Basking Ridge, NJ 07920 Phone: 973-542-3300
Gloria Chinenye Azubuike, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 131 Morristown Rd, Basking Ridge, NJ 07920 Phone: 908-630-9305
Jessica Kestler, APN, WHNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 140 Allen Rd, Basking Ridge, NJ 07920 Phone: 973-971-4600

Sheila Mcmenamin, - Medicare Nurse Practitioner in Basking Ridge, NJ

Contact Information

Provider's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medicare Reassignments

rVWF safe in patients with type 3 and severe type 1 von Willebrand disease, suggests interim study data

Drug use among young adults on the rise in U.S.

VA's final rule leads to underutilization of CRNAs in VHA facilities

FDA approves Gilotrif for patients with late stage non-small cell lung cancer

Study suggests substantial efforts are needed to help people with HIV durably suppress the virus

rVWF safe in patients with type 3 and severe type 1 von Willebrand disease, suggests interim study data

Drug use among young adults on the rise in U.S.

VA's final rule leads to underutilization of CRNAs in VHA facilities

FDA approves Gilotrif for patients with late stage non-small cell lung cancer

Study suggests substantial efforts are needed to help people with HIV durably suppress the virus

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

rVWF safe in patients with type 3 and severe type 1 von Willebrand disease, suggests interim study data

Drug use among young adults on the rise in U.S.

VA's final rule leads to underutilization of CRNAs in VHA facilities

FDA approves Gilotrif for patients with late stage non-small cell lung cancer

Study suggests substantial efforts are needed to help people with HIV durably suppress the virus

Nurse Practitioner Nurses in Basking Ridge, NJ